BACKGROUND: Allergic rhinitis is common, but a validated tool for comprehensive assessment of disease control is not available. OBJECTIVE: To develop a simple patient-completed instrument (the Rhinitis Control Assessment Test [RCAT]) to help detect problems with control of rhinitis symptoms. METHODS: During a visit to an allergy specialist, 410 patients with allergic rhinitis completed a Total Nasal Symptom Score (TNSS) assessment and the 26-item developmental RCAT. Physicians also completed a global assessment of rhinitis symptom control for each patient. RESULTS: Stepwise regression methods identified 6 items from the developmental RCAT (frequency of nasal congestion, sneezing, and watery eyes; sleep interference; activity avoidance; and self-assessed control) that were most predictive of the allergist's global rating of rhinitis symptom control. A summated rating scale from these 6 items showed good convergent validity (r > 0.70) with scale scores from the TNSS. The discriminant validity of the 6-item scale was demonstrated as mean RCAT scale scores differed significantly across groups of patients differing in physician-rated disease severity (F = 54.4), TNSS severity (F = 193.8), and physician-recommended change in therapy (F = 50.6) (P < .001 for all). CONCLUSIONS: The RCAT, a 6-item patient-completed instrument, has satisfactory psychometric properties and seems to be a valid tool for assessing control of allergic rhinitis. Further validation studies will provide confirmation.
BACKGROUND:Allergic rhinitis is common, but a validated tool for comprehensive assessment of disease control is not available. OBJECTIVE: To develop a simple patient-completed instrument (the Rhinitis Control Assessment Test [RCAT]) to help detect problems with control of rhinitis symptoms. METHODS: During a visit to an allergy specialist, 410 patients with allergic rhinitis completed a Total Nasal Symptom Score (TNSS) assessment and the 26-item developmental RCAT. Physicians also completed a global assessment of rhinitis symptom control for each patient. RESULTS: Stepwise regression methods identified 6 items from the developmental RCAT (frequency of nasal congestion, sneezing, and watery eyes; sleep interference; activity avoidance; and self-assessed control) that were most predictive of the allergist's global rating of rhinitis symptom control. A summated rating scale from these 6 items showed good convergent validity (r > 0.70) with scale scores from the TNSS. The discriminant validity of the 6-item scale was demonstrated as mean RCAT scale scores differed significantly across groups of patients differing in physician-rated disease severity (F = 54.4), TNSS severity (F = 193.8), and physician-recommended change in therapy (F = 50.6) (P < .001 for all). CONCLUSIONS: The RCAT, a 6-item patient-completed instrument, has satisfactory psychometric properties and seems to be a valid tool for assessing control of allergic rhinitis. Further validation studies will provide confirmation.
Authors: Daphne Koinis-Mitchell; Sheryl J Kopel; Julie Boergers; Elizabeth L McQuaid; Cynthia A Esteban; Ronald Seifer; Gregory K Fritz; Alvaro J Beltran; Robert B Klein; Monique LeBourgeois Journal: J Pediatr Psychol Date: 2015-05-18
Authors: Elizabeth A Erwin; Russell A Faust; Thomas A E Platts-Mills; Larry Borish Journal: Am J Rhinol Allergy Date: 2011 Sep-Oct Impact factor: 2.467
Authors: R A Gaudin; L P Hoehle; M-A Birkelbach; K M Phillips; A G Beule; D S Caradonna; S T Gray; A R Sedaghat Journal: HNO Date: 2017-12 Impact factor: 1.284
Authors: Haejin Kim; Linda Levin; Grace K LeMasters; Manuel Villareal; Sherry Evans; James E Lockey; Gurjit K Khurana Hershey; David I Bernstein Journal: Ann Allergy Asthma Immunol Date: 2012-02-28 Impact factor: 6.347
Authors: Daphne Koinis-Mitchell; Sheryl J Kopel; Julie Boergers; Kara Ramos; Monique LeBourgeois; Elizabeth L McQuaid; Cynthia A Esteban; Roald Seifer; Gregory K Fritz; Robert Klein Journal: J Clin Sleep Med Date: 2015-01-15 Impact factor: 4.062
Authors: Robin S Everhart; Sheryl J Kopel; Cynthia A Esteban; Elizabeth L McQuaid; Robert Klein; Christine E McCue; Daphne Koinis-Mitchell Journal: Ann Allergy Asthma Immunol Date: 2014-02-28 Impact factor: 6.347
Authors: Cynthia A Esteban; Robert B Klein; Sheryl J Kopel; Elizabeth L McQuaid; Gregory K Fritz; Ronald Seifer; Daniel York; Natalie Golova; Barbara Jandasek; Daphne Koinis-Mitchell Journal: Pediatr Allergy Immunol Pulmonol Date: 2014-06-01 Impact factor: 1.349